Autocrine S100B effects on astrocytes are mediated via RAGE

Journal of Neuroimmunology

Volumn 184, Issue 1-2, 2007, Pages 214-222

  Ponath, Gerald ^a   Schettler, Christiane ^a   Kaestner, Florian ^a   Voigt, Björn ^a   Wentker, Dennis ^a   Arolt, Volker ^a   Rothermundt, Matthias ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

autocrine pathway; Glia; proinflammatory cytokines; RAGE; S100B proteins

Indexed keywords

GENE PRODUCT; INTERLEUKIN 6; PROTEIN S100B; RECEPTOR FOR ADVANCED GLYCATION END PRODUCT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; AUTOCRINE EFFECT; CELL CULTURE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN-6; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE GROWTH FACTORS; PROTEIN-SERINE-THREONINE KINASES; S100 PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33847642792     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2006.12.011     Document Type: Article

References (51)

1. Adami C., Bianchi R., Pula G., and Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim. Biophys. Acta 1742 (2004) 169-177
2. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D.M., Schmidt A.M., and De Caterina R. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105 (2002) 816-822
3. Brett J., Schmidt A.M., Yan S.D., Zou Y.S., Weidman E., Pinsky D., Nowygrod R., Neeper M., Przysiecki C., Shaw A., et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am. J. Pathol. 143 (1993) 1699-1712
4. Bucciarelli L.G., Wendt T., Rong L., Lalla E., Hofmann M.A., Goova M.T., Taguchi A., Yan S.F., Yan S.D., Stern D.M., and Schmidt A.M. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell. Mol. Life Sci. 59 (2002) 1117-1128
5. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., and Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10061-10065
6. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33 (2001) 637-668
7. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc. Res. Tech. 60 (2003) 540-551
8. Dong Y., and Benveniste E.N. Immune function of astrocytes. Glia 36 (2001) 180-190
9. Fattori E., Lazzaro D., Musiani P., Modesti A., Alonzi T., and Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur. J. Neurosci. 7 (1995) 2441-2449
10. Gadient R.A., and Otten U.H. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog. Neurobiol. 52 (1997) 379-390
11. Gruol D.L., and Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15 (1997) 307-339
12. Guo L., Sawkar A., Zasadzki M., Watterson D.M., and Van Eldik L.J. Similar activation of glial cultures from different rat brain regions by neuroinflammatory stimuli and downregulation of the activation by a new class of small molecule ligands. Neurobiol. Aging 6 (2001) 975-981
13. Hayakata T., Shiozaki T., Tasaki O., Ikegawa H., Inoue Y., Toshiyuki F., Hosotubo H., Kieko F., Yamashita T., Tanaka H., Shimazu T., and Sugimoto H. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22 (2004) 102-107
14. 2+-binding S100 proteins in the central nervous system. Neurochem. Res. 24 (1999) 1097-1100
15. Hirota H., Kiyama H., Kishimoto T., and Taga T. Accelerated nerve regeneration in mice by upregulated expression of interleukin IL-6 and IL-6 receptor after trauma. J. Exp. Med. 183 (1996) 2627-2634
16. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., Avila C., Kambham N., Bierhaus A., Nawroth P., Neurath M.F., Slattery T., Beach D., McClary J., Nagashima M., Morser J., Stern D., and Schmidt A.M. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97 (1999) 889-901
17. Hu J., Ferreira A., and Van Eldik L.J. S100beta induces neuronal cell death through nitric oxide release from astrocytes. J. Neurochem. 69 (1997) 2294-2301
18. Huttunen H.J., Fages C., and Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274 (1999) 19919-19924
19. Huttunen H.J., Kuja-Panula J., Sorci G., Agneletti A.L., Donato R., and Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J. Biol. Chem. 275 (2000) 40096-40105
20. + T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J. Immunol. 171 (2003) 5697-5706
21. Lam A.G., Koppal T., Akama K.T., Guo L., Craft J.M., Samy B., Schavocky J.P., Watterson D.M., and Van Eldik L.J. Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB. Neurobiol. Aging 22 (2001) 765-772
22. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V., Goncalves C.A., Fonseca M., Hauck S., and Souza D.O. Increased serum S100B protein in schizophrenia: a study in medication-free patients. J. Psychiatr. Res. 35 (2001) 11-14
23. Li J., Qu X., and Schmidt A.M. Sp1-binding elements in the promoter of RAGE are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. J. Biol. Chem. 273 (1998) 30870-30878
24. Li Y., Barger S.W., Liu L., Mrak R.E., and Griffin W.S. S100beta induction of the proinflammatory cytokine interleukin-6 in neurons. J. Neurochem. 74 (2000) 143-150
25. Liu L., Li Y., Van Eldik L.J., Griffin W.S., and Barger S.W. S100B-induced microglial and neuronal IL-1 expression is mediated by cell type-specific transcription factors. J. Neurochem. 92 (2005) 546-553
26. Loddick S.A., Turnbull A.V., and Rothwell N.J. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18 (1998) 176-179
27. Marciano P.G., Eberwine J.H., Ragupathi R., Saatman K.E., Meaney D.F., and McIntosh T.K. Expression profiling following traumatic brain injury: a review. Neurochem. Res. 27 (2002) 1147-1155
28. Marz P., Cheng J.G., Gadient R.A., Patterson P.H., Stoyan T., Otten U., and Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 3251-3256
29. Mrak R.E., and Griffin W.S. The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol. Aging 22 (2001) 915-922
30. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005) 349-354
31. Muller N., Riedel M., Ackenheil M., and Schwarz M.J. Cellular and humoral immune system in schizophrenia: a conceptual re-evaluation. World J. Biol. Psychiatry 1 (2000) 173-179
32. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., and Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992) 14998-15004
33. Neumann H., Schmidt H., Cavalie A., Jenne D., and Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha. J. Exp. Med. 185 (1997) 305-316
34. Park I.H., Yeon S.I., Youn J.H., Choi J.E., Sasaki N., Choi I.H., and Shin J.S. Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol. Immunol. 40 (2004) 1203-1211
35. Penkowa M., Moos T., Carrasco J., Hadberg H., Molinero A., Bluethmann H., and Hidalgo J. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25 (1999) 343-357
36. Petrova T.V., Hu J., and Van Eldik L.J. Modulation of glial activation by astrocyte-derived protein S100B: differential responses of astrocyte and microglial cultures. Brain Res. 853 (2000) 74-80
37. Petzold A., Jenkins R., Watt H.C., Green A.J., Thompson E.J., Keir G., Fox N.C., and Rossor M.N. Cerebrospinal fluid S100B correlates with brain atrophy in Alzheimer's disease. Neurosci. Lett. 336 (2003) 167-170
38. Rothermundt M., Arolt V., and Bayer T.A. Review of Immunological and immunopathological findings in schizophrenia. Brain Behav. Immun. 15 (2001) 319-339
39. Rothermundt M., Missler U., Arolt V., Peters M., Leadbeater J., Wiesmann M., Rudolf S., Wandinger K.P., and Kirchner H. Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol. Psychiatry 6 (2001) 445-449
40. Rothermundt M., Peters M., Prehn J.H., and Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60 (2003) 614-632
41. Rothermundt M., Ponath G., Glaser T., Hetzel G., and Arolt V. S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology 29 (2004) 1004-1011
42. Rothermundt M., Falkai P., Ponath G., Abel S., Bürkle H., Diedrich M., Hetzel G., Peters M., Siegmund A., Pedersen A., Maier W., Schramm J., Suslow T., Ohrmann P., and Arolt V. Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol. Psychiatry 9 (2004) 897-899
43. Selinfreund R.H., Barger S.W., Pledger W.J., and Van Eldik L.J. Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3554-3558
44. Selmaj K.W., Farooq M., Norton W.T., Raine C.S., and Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144 (1990) 129-135
45. Valencia J.V., Mone M., Zhang J., Weetall M., Buxton F.P., and Hughes T.E. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 53 (2004) 743-751
46. Van Eldik L.J., and Zimmer D.B. Secretion of S-100 from rat C6 glioma cells. Brain Res. 436 (1987) 367-370
47. Vos P.E., Lamers K.J., Hendriks J.C., van Haaren M., Beems T., Zimmerman C., van Geel W., de Reus H., Biert J., and Verbeek M.M. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 62 (2004) 1303-1310
48. Wiesmann M., Wandinger K.P., Missler U., Eckhoff D., Rothermundt M., Arolt V., and Kirchner H. Elevated plasma levels of S-100b protein in schizophrenic patients. Biol Psychiatry 45 (1999) 1508-1511
49. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., and Stern D. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269 (1994) 9889-9897
50. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A.M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382 (1996) 685-691
51. Zimmer D.B., Cornwall E.H., Landar A., and Song W. The S100 protein family: history, function, and expression. Brain Res. Bull. 37 (1995) 417-429